Medicines for treating osteoporosis and reducing the risk of fragility fractures (review of TA160, TA161, TA204, TA464, TA791, TA991) [ID6689]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setrusumab for treating osteogenesis imperfecta [TSID12308]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC